Daikaffil Chemicals India Ltd
Incorporated in 1992, Daikaffil Chemicals India Ltd manufactures and trades Organic Dyes and
Intermediaries[1]
- Market Cap ₹ 28.0 Cr.
- Current Price ₹ 46.6
- High / Low ₹ 170 / 28.5
- Stock P/E
- Book Value ₹ 11.2
- Dividend Yield 0.00 %
- ROCE -27.8 %
- ROE -27.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Debtor days have improved from 175 to 54.4 days.
- Company's working capital requirements have reduced from 179 days to 79.0 days
Cons
- Stock is trading at 4.14 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -20.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.35 | 27.41 | 26.44 | 22.82 | 16.84 | 15.72 | 11.40 | 8.16 | 0.64 | 0.00 | 7.50 | 13.35 | |
| 31.36 | 24.24 | 21.77 | 19.53 | 15.04 | 13.88 | 11.23 | 10.20 | 2.58 | 2.25 | 9.29 | 15.21 | |
| Operating Profit | 2.99 | 3.17 | 4.67 | 3.29 | 1.80 | 1.84 | 0.17 | -2.04 | -1.94 | -2.25 | -1.79 | -1.86 |
| OPM % | 8.70% | 11.57% | 17.66% | 14.42% | 10.69% | 11.70% | 1.49% | -25.00% | -303.12% | -23.87% | -13.93% | |
| -0.16 | 0.55 | 0.55 | 0.85 | 0.42 | 0.85 | 0.55 | 0.47 | 0.41 | 0.71 | 0.47 | 0.05 | |
| Interest | 0.26 | 0.14 | 0.07 | 0.05 | 0.03 | 0.07 | 0.05 | 0.03 | 0.00 | 0.00 | 0.01 | 0.01 |
| Depreciation | 0.42 | 0.40 | 1.48 | 0.97 | 0.96 | 1.12 | 1.12 | 1.13 | 0.54 | 0.35 | 0.27 | 0.36 |
| Profit before tax | 2.15 | 3.18 | 3.67 | 3.12 | 1.23 | 1.50 | -0.45 | -2.73 | -2.07 | -1.89 | -1.60 | -2.18 |
| Tax % | 27.91% | 33.96% | 33.51% | 23.40% | 29.27% | 28.00% | -11.11% | -8.42% | 2.90% | 0.53% | -0.62% | -1.83% |
| 1.55 | 2.10 | 2.44 | 2.40 | 0.86 | 1.08 | -0.41 | -2.50 | -2.13 | -1.90 | -1.59 | -2.14 | |
| EPS in Rs | 2.58 | 3.50 | 4.07 | 4.00 | 1.43 | 1.80 | -0.68 | -4.17 | -3.55 | -3.17 | -2.65 | -3.57 |
| Dividend Payout % | 30.97% | 28.57% | 41.80% | 30.00% | 0.00% | 38.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 3% |
| 3 Years: | 175% |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 0% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | 22% |
| 1 Year: | -72% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -15% |
| 3 Years: | -21% |
| Last Year: | -27% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Reserves | 5.22 | 6.60 | 18.38 | 19.54 | 19.46 | 19.96 | 19.58 | 18.52 | 6.44 | 4.54 | 2.85 | 0.74 |
| 1.89 | 0.71 | 0.00 | 0.00 | 0.00 | 0.71 | 0.56 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 6.83 | 5.56 | 3.35 | 4.72 | 2.64 | 3.54 | 2.36 | 1.81 | 0.63 | 1.61 | 5.93 | 2.95 | |
| Total Liabilities | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 13.07 | 12.15 | 14.78 | 9.69 |
| 5.37 | 5.34 | 15.14 | 14.69 | 14.16 | 14.01 | 12.98 | 13.92 | 2.01 | 1.63 | 1.96 | 2.07 | |
| CWIP | 0.00 | 0.04 | 0.09 | 0.01 | 0.02 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.32 | 0.25 |
| Investments | 0.10 | 0.25 | 0.28 | 2.27 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.81 |
| 14.47 | 13.24 | 12.22 | 13.29 | 13.73 | 15.97 | 15.30 | 12.54 | 10.82 | 10.28 | 12.31 | 6.56 | |
| Total Assets | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 13.07 | 12.15 | 14.78 | 9.69 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.73 | 0.72 | 5.04 | 2.65 | 2.28 | 3.39 | 0.21 | -0.86 | -8.13 | 5.92 | -6.30 | 0.55 | |
| -0.51 | -0.47 | -0.93 | -2.70 | 1.86 | 0.14 | 0.21 | 0.20 | 0.57 | 0.60 | -0.56 | -0.64 | |
| -0.59 | -0.58 | -0.72 | -1.23 | -0.87 | -0.69 | -0.16 | -0.12 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.62 | -0.32 | 3.39 | -1.27 | 3.27 | 2.84 | 0.26 | -0.78 | -7.56 | 6.52 | -6.86 | -0.09 |
| Free Cash Flow | 1.26 | 0.32 | 4.11 | 2.22 | 1.85 | 3.24 | 0.12 | -0.97 | -8.14 | 6.05 | -7.37 | 0.14 |
| CFO/OP | 90% | 52% | 138% | 108% | 149% | 213% | 235% | 46% | 420% | -263% | 350% | -30% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 72.36 | 93.48 | 40.03 | 74.22 | 60.26 | 45.04 | 28.82 | 6.26 | 0.00 | 294.92 | 54.41 | |
| Inventory Days | 70.49 | 81.93 | 82.17 | 84.50 | 122.29 | 133.94 | 154.33 | 124.16 | 1,116.90 | 261.44 | 99.99 | |
| Days Payable | 85.28 | 69.49 | 34.20 | 80.69 | 39.27 | 80.53 | 59.90 | 7.49 | 21.90 | 341.10 | 60.14 | |
| Cash Conversion Cycle | 57.57 | 105.91 | 88.00 | 78.03 | 143.28 | 98.46 | 123.24 | 122.94 | 1,095.00 | 215.26 | 94.25 | |
| Working Capital Days | 47.71 | 83.63 | 76.89 | 93.25 | 113.14 | 73.37 | 99.89 | 108.25 | 4,956.02 | 279.35 | 79.01 | |
| ROCE % | 18.76% | 25.06% | 19.85% | 12.70% | 4.94% | 5.99% | -1.51% | -10.58% | -11.09% | -17.32% | -18.57% | -27.84% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Sales Percentage % |
|
|||||||||||
| Revenue from Operations (Gross Sales Value) INR Lakhs |
||||||||||||
| Headcount (Permanent Employees) Number |
||||||||||||
| Customer Concentration (Sales to Single Largest Customer) % |
||||||||||||
Extracted by Screener AI
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 2m
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
50m - Mikusu India bought 5,040 Daikaffil shares on June 15, 2026; holding rose to 49.40%.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
1d - Mikusu India bought 3,700 Daikaffil shares on June 12, lifting stake to 49.32%.
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
2d - Mikusu India bought 3,700 shares of Daikaffil Chemicals on June 12, 2026, raising stake to 49.32%.
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
12 Jun - Mikusu India bought 8,144 shares on June 11, 2026; stake rose to 49.26%.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
DCIL is in the business of manufacturing
and trading of organic chemicals and intermediaries and trading of chemicals